In contrast, favorable clinical response to anti-PD-1 therapy was, among others, associated with enhanced expression of granzyme B on tumor-infiltrated CD8(+) cytotoxic T cells (CTLs) [16]. The gene discussed is CD8A; the disease is neoplasm.